(Q51757810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Signe Regner Michaelsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Rikke Darling Rasmussen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Mette Villingshøj

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Hans Skovgaard Poulsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Petra Hamerlik

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

20 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

21-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13402-016-0301-9

26 March 2020

exact match

0 references

cites work

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Epigenetics: principles and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Epigenetic mechanisms in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Is glioblastoma an epigenetic malignancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

HDAC expression and clinical prognosis in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

New and emerging HDAC inhibitors for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Assessment of cetuximab efficacy by bioluminescence monitoring of intracranial glioblastoma xenograft in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Nitrosoureas in the Management of Malignant Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Replication protein A and gamma-H2AX foci assembly is triggered by cellular response to DNA double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Glioblastoma multiforme: a review of where we have been and where we are going

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Altered primary chromatin structures and their implications in cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

A role of the mitotic spindle checkpoint in the cellular response to DNA replication stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0301-9

Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming

21 January 2018

1 reference

12 December 2020

Protected from the inside: endogenous histone deacetylase inhibitors and the road to cancer

1 reference

12 December 2020

Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination

1 reference

12 December 2020

Vorinostat(SAHA) Promotes Hyper-Radiosensitivity in Wild Type p53 Human Glioblastoma Cells.

1 reference

12 December 2020

Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway

1 reference

12 December 2020

Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis

1 reference

12 December 2020

Response of medulloblastoma cells to vincristine and lomustine: role of TRKC, CTNNB1 and STK15.

1 reference

12 December 2020

10.1007/S13402-016-0301-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27766591%20AND%20SRC:MED&resulttype=core&format=json

release_dh5n6ehgkjaqdj7fgaqzidxvuu

26 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dh5n6ehgkjaqdj7fgaqzidxvuu

24 November 2022

mapped directly with Wikidata item

1 reference